Cord Blood Stem Cell TransplantationFetal BloodHematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell TransplantationMonocrotophosTransplantation, AutologousTransplantation, HomologousStem Cell TransplantationPenile ImplantationStem CellsHematopoietic Stem CellsTransplantation ConditioningGraft vs Host DiseaseBlood BanksHematologic NeoplasmsAntigens, CD34Hematopoietic Stem Cell MobilizationBone Marrow TransplantationMelphalanGranulocyte Colony-Stimulating FactorGraft SurvivalLeukapheresisTransplantation ChimeraCombined Modality TherapyCell DifferentiationTreatment OutcomeMyeloablative AgonistsBusulfanTissue DonorsMultiple MyelomaCyclophosphamideRecurrenceBlood Component RemovalMice, SCIDRemission InductionWhole-Body IrradiationAntineoplastic Combined Chemotherapy ProtocolsHistocompatibility TestingCells, CulturedHematopoiesisHistocompatibilityLiver TransplantationLeukemiaImmunosuppressive AgentsLymphoma, Non-HodgkinRetrospective StudiesVidarabineAntineoplastic Agents, AlkylatingDisease-Free SurvivalMesenchymal Stem Cell TransplantationGraft vs Leukemia EffectEtoposideInfectionSurvival RateTime FactorsThiotepaLeukemia, Myeloid, AcuteSurvival AnalysisBlood CellsSalvage TherapyTransplantation, IsogeneicHematologic DiseasesCell TransplantationEmbryonic Stem CellsKidney TransplantationPOEMS SyndromeAmyloidosisMyelodysplastic SyndromesHodgkin DiseaseBone Marrow CellsSpinal CordAdult Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHLA AntigensMice, Inbred NODCytarabineAnemia, AplasticCytomegalovirus InfectionsVincristineFollow-Up StudiesPrecursor Cell Lymphoblastic Leukemia-LymphomaLymphomaCarmustineBone MarrowFatal OutcomeTransplantation ImmunologyLymphocyte DepletionPlatelet CountIfosfamideChimerismCell LineageImmunosuppressionGraft vs Tumor EffectCyclosporineUnrelated DonorsFlow CytometrySiblingsPluripotent Stem CellsImmunophenotypingAntigens, CD